Seattle Genetics Inc. (SGEN) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Seattle Genetics Inc. (NASDAQ: SGEN) reported Q2 EPS of ($0.14), $0.09 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $68.3 million versus the consensus estimate of $65.04 million.
For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Workhorse Group (WKHS) Misses Q2 EPS by 77c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
